Matematik
Protease
84%
Inhibitor
65%
Therapy
59%
Resistance
55%
Mutation
52%
Genotype
26%
Infection
21%
Sequencing
8%
Clinical Trials
7%
Standards
4%
Landbrug og biologi
chronic hepatitis C
100%
Denmark
56%
proteinase inhibitors
55%
mutation
35%
therapeutics
35%
genotype
11%
hepatitis C
11%
infection
10%
proteinases
9%
hepatitis B
9%
relapse
8%
interferons
7%
clinical trials
6%
sequence diversity
6%
demographic statistics
5%
reverse transcriptase polymerase chain reaction
5%
Geo- og miljøvidenskab
hepatitis
72%
therapy
55%
mutation
52%
inhibitor
48%
genotype
24%
infection
20%
trial
6%
rate
2%
analysis
1%
Medicin og biovidenskab
Denmark
55%
Chronic Hepatitis C
54%
Protease Inhibitors
54%
Mutation
29%
Genotype
9%
Therapeutics
8%
Peptide Hydrolases
7%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
6%
telaprevir
6%
Infections
6%
Ribavirin
4%
Hepatitis C
4%
Standard of Care
4%
Treatment Failure
4%
Hepatitis B
4%
Interferons
4%
Antiviral Agents
3%
Clinical Trials
2%
Demography
2%
Databases
2%
Polymerase Chain Reaction
2%
Recurrence
2%
Teknik og materialevidenskab
Peptide Hydrolases
79%
Interferons
18%